Neurotechnology for cognitive enhancement adapted to a sanitary context.

Request Information


Neurotechnology for cognitive enhancement adapted to a well-being context

Request Information

Neurotechnology for cognitive enhancement

ELEVVO is a technology designed to optimize the functioning of the brain areas related with cognitive performance, and oriented to professionals within the fields of health and well-being.

+ 10

International scientific publications

+ 400

Users of the technology

+ 90,000

Brain and cognitive recordings


Average improvement in working memory and attention

The ELEVVO technology has been scientifically validated

Developed in collaboration with:

  • Hospital Universitario Miguel Servet
  • Instituto Aragónes de Ciencias de la Salud
  • CNRS
  • University of Otago

Co-financed by:

  • Gobierno de España
  • European Commission

What ELEVVO can improve

ELEVVO is indicated to improve cognitive performance regarding basic functions such as working memory, processing speed, sustained attention and concentration, as well as attention switching.

MEDICAL Adapted for the use in a sanitary context
WELLNESS Adapted for the use in a well-being context

Professionals tell you what they have achieved with ELEVVO

ELEVVO has been used by professionals of the sectors of health, well-being, and personal development.


ELEVVO is based on a 6-year research and development by BitBrain Technologies in collaboration with the University of Zaragoza, the Aragon Institute of Health Science and other international entities.


Endorsed Scientifics tell what’s behind ELEVVO

ELEVVO has been endorsed by top level international publications in fields such as Behavioural Neuroscience, Applied Psychology and Biomedical Engineering.

Dr. Javier García Campayo

Psychiatry Doctor at Miguel Servet Hospital. Principal Director of the Primary Care research group of the Aragon Institute of Health Science, Spain.

“ELEVVO has enabled us to address the symptomatology of cognitive disorders associated with determined pathologies from a clinical perspective. It is a suitable intervention, which complements the conventional treatment methods.”

Dr. Javier Mínguez

Professor and PhD in Computer Engineering by the University of Zaragoza. Principal Director of the Neurotechnology research group in the University of Zaragoza, Spain.

“ELEVVO integrates insights from brain-machine interfaces to the field of cognitive neurohabilitation: the technology is constantly and individually adapting to the brain of each user in order to optimize the intervention result.”

Dr. Eduardo Rocón

Principal Investigator and PhD in Industrial Engineering by Technical University of Madrid. Director of the Neural and Cognitive Engineering research group in the Spanish National Research Council’s (CSIC), Spain.

“ELEVVO is a new technology that produces neuroplastic changes in brain areas responsible for cognitive performance. Optimization of the cognitive functions is associated with these brain changes, which are the neurobiological base of its effectiveness.”

Contact us

Leave your details and we will contact you very soon.